• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPHER METHKE GMBH & CO. KG SHUNTASSISTANT 15; HYDROCEPHALUS VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPHER METHKE GMBH & CO. KG SHUNTASSISTANT 15; HYDROCEPHALUS VALVES Back to Search Results
Model Number FV250T
Device Problem Obstruction of Flow (2423)
Patient Problem Failure of Implant (1924)
Event Date 11/21/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).When additional information is received, a follow up report will be submitted.
 
Event Description
It was reported by the healthcare professional "8y 2m po overdrainage of the valve.Explanted.".
 
Manufacturer Narrative
Manufacturing and quality control data: all parameters have been inspected and approved during the manufacturing process.All parameters have been assessed as meeting specifications.Investigation: visual inspection: scratches on the outer housing of the valve were observed through the visual inspection.No significant deformations or damages were detected.Permeability test: a permeability test has shown that the valve is permeable.However a partial blockage was indicated by slow drainage during the test.Computer controlled test: to test the opening pressure, we use a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valve was tested in the vertical position.The results show that the valve is operating within the accepted tolerance.Results: we have dismantled the valve.Inside the valve we have found a build-up of substances (likely protein).Based on out investigation, we are unable to substantiate the claim of overdrainage.The valve operates within the specified tolerances.However, it is possible that the deposits observed inside the valve could have caused the malfunction in the past.As described in our literature, the problem encountered is one of the known, inevitable risks of hc-therapy by shunt implants.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SHUNTASSISTANT 15
Type of Device
HYDROCEPHALUS VALVES
Manufacturer (Section D)
CHRISTOPHER METHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key8157851
MDR Text Key130169722
Report Number3004721439-2018-00296
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K110206
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 12/21/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2015
Device Model NumberFV250T
Device Catalogue NumberFV250T
Device Lot Number4502844673
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/26/2018
Distributor Facility Aware Date11/27/2018
Device Age8 YR
Initial Date Manufacturer Received 11/26/2018
Initial Date FDA Received12/12/2018
Supplement Dates Manufacturer Received12/12/2018
Supplement Dates FDA Received01/07/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age10 YR
Patient Weight48
-
-